HOOK
Price
$1.12
Change
-$0.08 (-6.67%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
14.47M
RIGL
Price
$19.47
Change
-$0.06 (-0.31%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
349.94M
Ad is loading...

HOOK vs RIGL

Header iconHOOK vs RIGL Comparison
Open Charts HOOK vs RIGLBanner chart's image
HOOKIPA Pharma
Price$1.12
Change-$0.08 (-6.67%)
Volume$840
Capitalization14.47M
Rigel Pharmaceuticals
Price$19.47
Change-$0.06 (-0.31%)
Volume$4.43K
Capitalization349.94M
HOOK vs RIGL Comparison Chart
Loading...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOOK vs. RIGL commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOOK is a Hold and RIGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (HOOK: $1.20 vs. RIGL: $19.53)
Brand notoriety: HOOK and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOOK: 55% vs. RIGL: 138%
Market capitalization -- HOOK: $14.47M vs. RIGL: $349.94M
HOOK [@Biotechnology] is valued at $14.47M. RIGL’s [@Biotechnology] market capitalization is $349.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOOK’s FA Score shows that 1 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • HOOK’s FA Score: 1 green, 4 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both HOOK and RIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOOK’s TA Score shows that 3 TA indicator(s) are bullish while RIGL’s TA Score has 4 bullish TA indicator(s).

  • HOOK’s TA Score: 3 bullish, 3 bearish.
  • RIGL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both HOOK and RIGL are a good buy in the short-term.

Price Growth

HOOK (@Biotechnology) experienced а -14.89% price change this week, while RIGL (@Biotechnology) price change was -12.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.61%. For the same industry, the average monthly price growth was -8.15%, and the average quarterly price growth was -7.40%.

Reported Earning Dates

HOOK is expected to report earnings on Nov 13, 2024.

RIGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+0.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($350M) has a higher market cap than HOOK($14.5M). RIGL YTD gains are higher at: 16.112 vs. HOOK (-40.299). RIGL has higher annual earnings (EBITDA): 13.7M vs. HOOK (-39.82M). RIGL (61.1M) and HOOK (59.8M) have equal amount of cash in the bank . HOOK has less debt than RIGL: HOOK (2.83M) vs RIGL (60.2M). RIGL has higher revenues than HOOK: RIGL (157M) vs HOOK (50M).
HOOKRIGLHOOK / RIGL
Capitalization14.5M350M4%
EBITDA-39.82M13.7M-291%
Gain YTD-40.29916.112-250%
P/E RatioN/A19.79-
Revenue50M157M32%
Total Cash59.8M61.1M98%
Total Debt2.83M60.2M5%
FUNDAMENTALS RATINGS
HOOK vs RIGL: Fundamental Ratings
HOOK
RIGL
OUTLOOK RATING
1..100
5071
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
9095
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
5n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOOK's Valuation (10) in the Pharmaceuticals Major industry is significantly better than the same rating for RIGL (94) in the Biotechnology industry. This means that HOOK’s stock grew significantly faster than RIGL’s over the last 12 months.

HOOK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as RIGL (100) in the Biotechnology industry. This means that HOOK’s stock grew similarly to RIGL’s over the last 12 months.

HOOK's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as RIGL (100) in the Biotechnology industry. This means that HOOK’s stock grew similarly to RIGL’s over the last 12 months.

HOOK's Price Growth Rating (90) in the Pharmaceuticals Major industry is in the same range as RIGL (95) in the Biotechnology industry. This means that HOOK’s stock grew similarly to RIGL’s over the last 12 months.

RIGL's P/E Growth Rating (99) in the Biotechnology industry is in the same range as HOOK (100) in the Pharmaceuticals Major industry. This means that RIGL’s stock grew similarly to HOOK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOOKRIGL
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X78532.000000-2069.039000
-2.57%
Bitcoin cryptocurrency
SPY560.58-15.34
-2.66%
SPDR® S&P 500® ETF Trust
AAPL227.48-11.59
-4.85%
Apple
GME22.42-1.58
-6.58%
GameStop Corp
TSLA222.15-40.52
-15.43%
Tesla

HOOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOOK has been closely correlated with DARE. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if HOOK jumps, then DARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOOK
1D Price
Change %
HOOK100%
-5.51%
DARE - HOOK
87%
Closely correlated
N/A
CLNN - HOOK
86%
Closely correlated
-3.93%
PHIO - HOOK
81%
Closely correlated
-0.77%
AZTR - HOOK
81%
Closely correlated
-0.29%
IMRN - HOOK
79%
Closely correlated
+1.07%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been closely correlated with CLNN. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RIGL jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-4.82%
CLNN - RIGL
92%
Closely correlated
-3.93%
DARE - RIGL
88%
Closely correlated
N/A
PHIO - RIGL
84%
Closely correlated
-0.77%
AZTR - RIGL
84%
Closely correlated
-0.29%
IMRN - RIGL
82%
Closely correlated
+1.07%
More